Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06595784
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-05
Brief Title:
The HELlenic Thoracic Society Initiative for CΟPD and CVD
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The HELlenic Thoracic Society Initiative for CΟPD and CVD
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HELICOPD
Brief Summary:
COPD is one of the most common respiratory diseases in Greece and maybe more than half a million Greek citizens suffer both from COPD and CVD however their characteristics and management remain unknown HELICOPD is a national multicenter prospective non-interventional study designed to contribute to better understanding and depicting the demographic and clinical characteristics of this population the COPD- and CVD-related adverse events in a two-years period their quality of life and the healthcare resources use The study is initiated and coordinated by the Hellenic Thoracic Society
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None